AbbVie (ABBV) is closing in on a deal to buy Apogee Therapeutics for $10.9 billion in cash, according to a Reuters report citing people familiar with the matter in the Financial Times. The price values Read more…
USC Schaeffer Institute’s Dana Goldman, PhD., discusses new research on aging, work, and public policy — and why updating retirement rules matters now. Key topics covered: Why rising life expectancy demands policy updates to Social Read more…
When asked why they can’t afford a house, many Americans would probably respond that home prices or mortgage rates are too high. Don’t get me wrong: Rates and prices are definitely serious issues for many Read more…